Chemokine receptor oligomerization: A further step toward chemokine function

被引:34
|
作者
Martinez Munoz, Laura [1 ]
Lopez Holgado, Borja [1 ]
Martinez-A, Carlos [1 ]
Miguel Rodriguez-Frade, Jose [1 ]
Mellado, Mario [1 ]
机构
[1] CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28049 Madrid, Spain
关键词
Chemokine receptors; Oligomerization; GPCR; HIV-1; INFECTION; CONFORMATIONAL-CHANGES; CELL-MIGRATION; CXCR4; CCR5; DIMERIZATION; LIGAND; HETERODIMERIZATION; RHODOPSIN; REVEALS;
D O I
10.1016/j.imlet.2012.04.012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A broad array of biological responses including cell polarization, movement, immune and inflammatory responses, as well as prevention of HIV-1 infection, are triggered by the chemokines, a family of secreted and structurally related chemoattractant proteins that bind to class A-specific seven-transmembrane receptors linked to G proteins. Chemokines and their receptors should not be considered isolated entities, as they act in complex networks. Chemokines bind as oligomers, or oligomerize after binding to glycosaminoglycans on endothelial cells, and are then presented to their receptors on target cells, facilitating the generation of chemoattractant gradients. The chemokine receptors form homo- and heterodimers, as well as higher order structures at the cell surface. These structures are dynamic and are regulated by receptor expression and ligand levels. Complexity is even greater, as in addition to regulation by cytokines and decoy receptors, chemokine and receptor levels are affected by proteolytic cleavage and other protein modifications. This complex scenario should be considered when analyzing chemokine biology and the ability of their antagonists to act in vivo. Strategies based on blocking or stabilizing ligand and receptor dimers could be alternative approaches that might have broad therapeutic potential. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 50 条
  • [31] Haplotype analysis of chemokine and chemokine receptor polymorphisms.
    Clark, VJ
    Peterson, RJ
    Dean, M
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 399 - 399
  • [32] Chemokine and chemokine receptor expression in keloid and normal fibroblasts
    Nirodi, CS
    Devalaraja, R
    Nanney, LB
    Arrindell, S
    Russell, S
    Trupin, J
    Richmond, A
    WOUND REPAIR AND REGENERATION, 2000, 8 (05) : 371 - 382
  • [33] Inhibition of chemokine receptor function by membrane cholesterol oxidation
    Nguyen, DH
    Taub, DD
    EXPERIMENTAL CELL RESEARCH, 2003, 291 (01) : 36 - 45
  • [34] Adenylate cyclase assays to measure chemokine receptor function
    Horuk, R
    CHEMOKINE RECEPTORS, 1997, 288 : 326 - 339
  • [35] Chemokine receptor sharing
    Resh, MD
    TRENDS IN MICROBIOLOGY, 2000, 8 (02) : 59 - 59
  • [36] Chemokine Receptor Antagonists
    Pease, James
    Horuk, Richard
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (22) : 9363 - 9392
  • [37] Chemokine receptor antagonists
    Horuk, R
    Ng, HP
    MEDICINAL RESEARCH REVIEWS, 2000, 20 (02) : 155 - 168
  • [38] Chemokine and chemokine receptor dynamics during genital chlamydial infection
    Belay, T
    Eko, FO
    Ananaba, GA
    Bowers, S
    Moore, T
    Lyn, D
    Igietseme, JU
    INFECTION AND IMMUNITY, 2002, 70 (02) : 844 - 850
  • [39] Chemokine and chemokine receptor expression in cultured microglia and in rat brain
    Boddeke, HWGM
    Spleiss, O
    Gourmala, N
    Ren, LQ
    Gebicke-Härter, PJ
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 485 - 485
  • [40] Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies
    Kufareva, Irina
    Salanga, Catherina L.
    Handel, Tracy M.
    IMMUNOLOGY AND CELL BIOLOGY, 2015, 93 (04): : 372 - 383